French drugmaker Aventis Pharma is betting on $23-24m sales this year on the Romanian market, up from last year’s $19.5 million. “This is indeed an ambitious target, considering we are not expecting a boom in sales to hospitals, but we are planning to bring new products and boost sales through pharmacies,” said Nicolae Coja, general manager of the Aventis subsidiary. The company distributes the bulk of its products to hospitals, hence the somewhat “sluggish” collection of bills. ZF
ZF English
Aventis Romania sees 18% increase
French drugmaker Aventis Pharma is betting on $23-24m sales this year on the Romanian market, up from last year's $19.5 million. "This is indeed an ambitious target, considering we are not expecting a boom in sales to hospitals, but we are planning to bring new products and boost sales through pharmacies," said Nicolae Coja, general manager of the Aventis subsidiary